Amanote Research
Register
Sign In
IDH1 and IDH2 Mutations in Tumorigenesis: Mechanistic Insights and Clinical Perspectives
Clinical Cancer Research
- United States
doi 10.1158/1078-0432.ccr-12-1773
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
October 14, 2012
Authors
H. Yang
D. Ye
K.-L. Guan
Y. Xiong
Publisher
American Association for Cancer Research (AACR)
Related search
IDH1 and IDH2 Mutations in Myelodysplastic Syndromes and Role in Disease Progression
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Computational Analysis of IDH1, IDH2, and TP53 Mutations in Low-Grade Gliomas Including Oligodendrogliomas and Astrocytomas
Cancer Informatics
Cancer Research
Oncology
Adiponectin: Mechanistic Insights and Clinical Implications
Diabetologia
Internal Medicine
Endocrinology
Metabolism
Diabetes
IDH1 and IDH2 Mutations in Therapy-Related Myelodysplastic Syndrome and Acute Myeloid Leukemia Are Associated With a Normal Karyotype and With Der(1;7)(q10;p10)
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Mitotic Inheritance of PRC2-Mediated Silencing: Mechanistic Insights and Developmental Perspectives
Frontiers in Plant Science
Plant Science
PIK3CA Somatic Mutations in Breast Cancer: Mechanistic Insights From Langevin Dynamics Simulations
Proteins: Structure, Function and Genetics
Biochemistry
Structural Biology
Molecular Biology
IDH1 Gene Mutations: A New Paradigm in Glioma Prognosis and Therapy?
Oncologist
Cancer Research
Medicine
Oncology
IDH1/2 Mutations Predict Shorter Survival in Chondrosarcoma
Journal of Cancer
Oncology
Expanding the Spectrum of IDH1 Mutations in Gliomas
Modern Pathology
Forensic Medicine
Pathology
